17 years of research by more than 30,000 people tell you the dangers of eating red meat

Share This Post

The latest shows that a diet without red meat significantly reduces the risk of colon cancer in British women. Researchers at the University of Leeds evaluated whether red meat, poultry, fish or vegetarian diets are associated with colon and rectal cancer risk. When comparing the effects of these diets on the development of cancer in specific subpopulations of the colon, they found that those who frequently ate red meat had a higher percentage of cancers in the distal colon than those without a red meat diet-that is, cancers were found in the distal part of the colon, ie Where to store feces.

The study included 32,147 women from England, Wales and Scotland. They were recruited and surveyed by the World Cancer Research Foundation from 1995 to 1998 and tracked for an average of 17 years. In addition to reporting their dietary habits, a total of 462 cases of colorectal cancer, 335 cases of colon cancer, and 119 cases of distant colon cancer were recorded.

By 2030, it is expected that there will be more than 2.2 million new cases of colorectal cancer worldwide, which is the third most commonly diagnosed cancer among British  women. Previous studies have shown that eating large amounts of red meat and processed meat increases the risk of colorectal cancer. It is estimated that about one-fifth of bowel cancers in the UK are related to eating these meats. This study of more than 30,000 people lasted 17 years, and the results are extremely convincing. How should you prevent colorectal cancer, you should know?

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

How Targeted Therapy is Revolutionizing Advanced Cancer Treatment

How Targeted Therapy is Revolutionizing Advanced Cancer Treatment?

In the field of oncology, the emergence of targeted therapy has revolutionized the treatment landscape for advanced cancers. Unlike conventional chemotherapy, which broadly targets rapidly dividing cells, targeted therapy aims to selectively attack cancer cells while minimizing damage to normal cells. This precision approach is made possible by identifying specific molecular alterations or biomarkers that are unique to cancer cells. By understanding the molecular profiles of tumors, oncologists can tailor treatment regimens that are more effective and less toxic. In this article, we delve into the principles, applications, and advancements of targeted therapy in advanced cancer.

Utilizing Immunotherapy to Treat Late-Stage Cancers

Utilizing Immunotherapy to Treat Late-Stage Cancers

  Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have demonstrated minimal effectiveness with standard medicines. This

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy